DarioHealth Corp. (DRIO) 当前追踪市盈率 (P/E) 为 5.7, 前瞻市盈率为 10.2. 追踪盈利收益率为 17.52%, 前瞻盈利收益率 9.85%. PEG 0.04 (Peter Lynch 低估标准 ≤1.0). 格雷厄姆数为 $6.19.
本页证实的标准:
SharesGrow 综合评分： 54/100 其中 2/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -31.1 | 0.70 | -51.70 | 120.65 | - |
| 2017 | -19.6 | 0.90 | 78.28 | 59.67 | - |
| 2018 | -20.4 | 0.38 | 40.71 | 49.14 | - |
| 2019 | -16.8 | 0.35 | 15.74 | 39.33 | - |
| 2020 | -57.9 | 1.98 | 60.54 | 224.96 | - |
| 2021 | -56.1 | 3.38 | 50.31 | 209.81 | - |
| 2022 | -32.5 | 0.75 | 25.29 | 73.15 | - |
| 2023 | -16.4 | 0.62 | 16.79 | 47.96 | - |
| 2024 | -14.9 | 0.24 | 8.82 | 23.50 | - |
| 2025 | -13.5 | 0.05 | 8.32 | 25.26 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-41.85 | $2.8M | $-10.89M | -388.4% |
| 2017 | $-32.70 | $5.17M | $-15.74M | -304.5% |
| 2018 | $-15.21 | $7.39M | $-17.8M | -240.8% |
| 2019 | $-7.84 | $7.56M | $-17.77M | -235% |
| 2020 | $-4.86 | $7.58M | $-28.99M | -382.6% |
| 2021 | $-4.63 | $20.51M | $-76.76M | -374.2% |
| 2022 | $-2.63 | $27.66M | $-62.19M | -224.9% |
| 2023 | $-1.93 | $20.35M | $-59.43M | -292% |
| 2024 | $-0.61 | $27.04M | $-42.75M | -158.1% |
| 2025 | $1.24 | $22.36M | $-41.71M | -186.6% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $-4.36 | $-5.46 – $-3.26 | $26.56M | $26.53M – $26.58M | 3 |
| 2027 | $-1.52 | $-1.56 – $-1.45 | $38.93M | $37.65M – $39.74M | 2 |
| 2028 | $0.74 | $0.71 – $0.76 | $54.05M | $52.27M – $55.18M | 1 |
| 2029 | $6.50 | $6.22 – $6.68 | $75M | $72.54M – $76.58M | 1 |
| 2030 | $10.80 | $10.34 – $11.10 | $100M | $96.71M – $102.1M | 1 |
